An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

The more precisely we want to examine the human retina, the more clearly one of the fundamental limits of physics becomes ...

Discover how medical 3D printing creates patient-specific devices and custom prosthetics. Read our guide to clinical ...

Sovato CEO Brian Miller, who spent 25 years at Computer Motion and Intuitive Surgical, explains why remote surgery is ...

Brittany Cartwright recently clarified rumors surrounding her cosmetic procedures during an interview with Us Weekly. The ...

Sentante co-founder and CEO Edvardas Satkauskas explains what's special about his startup’s remote endovascular robotics ...

AI acts as a feature to support existing solutions, which enables predictions and control process improvements beyond ...

In this exclusive interview with Healio, Cosimo Mazzotta, MD, PhD, one of the pioneers of corneal cross-linking, reverses the ...

The diagnosis is his. The admin, stress, and emotional work is too often hers.

Ascendis Pharma A/S (Nasdaq: ASND) today announced that it has called all $575.0 million aggregate principal amount of its outstanding 2.25% Convertible Senior Notes due 2028 (the “notes”) (CUSIP No.

Recent studies show some systems recommend different treatments for identical patients based only on demographic labels, a ...